Mortality in systemic sclerosis: an international meta-analysis of individual patient data.
about
Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosisTrends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studiesSystemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies.Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases.Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis.Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive testsDiagnosis and management of pulmonary hypertension in systemic sclerosis.Clinical and genetic factors predictive of mortality in early systemic sclerosis.Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.Systemic sclerosis-dermatological aspects. Part 1: Pathogenesis, epidemiology, clinical findings.Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohortDissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.Genetics of scleroderma: implications for personalized medicine?Lidocaine for systemic sclerosis: a double-blind randomized clinical trial.Meta-analysis in medical research.Mortality in systemic sclerosis-a single centre study from the UK.On the respiratory mechanics measured by forced oscillation technique in patients with systemic sclerosis.Right bundle branch block: a predictor of mortality in early systemic sclerosis.Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signaling.Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.The right ventricle in scleroderma (2013 Grover Conference Series).Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsyAssociation of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseChanges in causes of death in systemic sclerosis, 1972-2002Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationEarly- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients.Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.The Extrapulmonary Manifestations of Systemic Sclerosis on Chest High Resolution Computed Tomography.Primary myocardial involvement in systemic sclerosis.The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factorsThe American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisNew therapeutic strategies in the management of systemic sclerosis.The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in sclerodermamiR-155 in the progression of lung fibrosis in systemic sclerosis.T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.
P2860
Q26864740-A8E5528E-8C81-48EB-9C35-48E1A8BDD781Q26864958-2CC88372-0AFA-4DBB-A8DA-31D73CB98E29Q27687340-844F3ADA-C687-4FE0-B85B-6B41BCCBE282Q30355778-2320F9EC-11CB-468E-B5C9-E2B211E93FF0Q30432895-5B29F359-4B4A-432B-9019-129D76EE4EF1Q30453741-107DE63A-FE4A-4ACC-8A57-A23FE020EB29Q33832379-43009056-5EE0-4AFA-BB02-38BC6188756DQ33903786-91BC099D-9C6A-465E-8D3B-C946F0CEC2A1Q34032884-86B7A713-E83B-4462-95C5-735F02B2E840Q34267840-C96100F4-0383-4B6E-A929-BFBBDAFABF59Q34295337-681C898D-E395-47F7-8642-C19ACC732C69Q34346178-CEB930F3-BC98-40AE-B7F3-562E3FB55CF0Q34485231-7813E26E-8C75-4C4A-9DAA-21136E8DB3B5Q34545752-69818963-502A-43BD-9385-3308653421B0Q34585544-63960A67-EDD7-44F1-B997-DC492CFAC36AQ34627273-DDB3ADB3-930F-40D9-B36E-00D1E19136A2Q34653727-31F01198-EBB8-473F-BCE1-2996F0809BFAQ34700520-D2C8C508-203D-485F-BE60-F3428060A11AQ35036736-AEB8A31F-319D-4469-AF39-E3C7AE9247AEQ35108749-BCD39A30-E1CE-42D7-A4A2-7D48EC63F57FQ35156880-2572E11C-F4EC-4F99-897C-02C9A8EE1EDCQ35517421-B73B60CC-DF15-44FC-8C79-1051F514302DQ35597574-A5A49AEB-B632-4F2D-A6B1-08E301FBFF4FQ35628723-3D17FA4F-EA55-4282-9DA1-788165683776Q35851777-5597EC6E-D232-41F1-9DC9-903615FAD95AQ35953368-E0662285-6588-4F3F-88AD-E5338770182AQ35954516-4003C179-C99A-472B-B62A-229D429FB840Q36020897-FAA73C4C-80E6-4E76-BC1D-FCD2CBB2A8D1Q36193496-976B79E1-44A5-42E5-957B-C24364640F5CQ36289875-D8CB5FD5-7268-40FA-AFB2-366680927D3BQ36555885-F340BC0D-A2EB-429E-A4AD-B21F60F8B301Q36596341-9C4C2640-11DC-47BA-B020-85AE9FA7B270Q36645934-516ADA3D-89D9-41F8-B791-1740054B5D95Q36757042-D4237582-BA2F-4621-8C08-CB6FAA12ADB5Q36758822-2F9B7EF0-4353-4AB6-883B-B1C7EEE8DE07Q36765781-8D2A6441-421F-4184-B5A8-D180C25F1F85Q36773107-EC00897E-35A1-4CCF-A105-22C42732E708Q36871425-D8983624-9F9F-4E5D-B007-9D6B901D65F2Q37064457-31B948AA-D36D-415F-96CA-6C1DD7CF741FQ37143961-C1DCDDA7-19DF-401C-B7ED-FA6DC3E687B8
P2860
Mortality in systemic sclerosis: an international meta-analysis of individual patient data.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Mortality in systemic sclerosi ...... is of individual patient data.
@ast
Mortality in systemic sclerosi ...... is of individual patient data.
@en
type
label
Mortality in systemic sclerosi ...... is of individual patient data.
@ast
Mortality in systemic sclerosi ...... is of individual patient data.
@en
prefLabel
Mortality in systemic sclerosi ...... is of individual patient data.
@ast
Mortality in systemic sclerosi ...... is of individual patient data.
@en
P2093
P50
P1476
Mortality in systemic sclerosi ...... is of individual patient data.
@en
P2093
Anna-Bettina Haidich
Clement J Michet
Frank van den Hoogen
Haralampos M Moutsopoulos
Hidekata Yasuoka
Jacob M van Laar
Liane Te Boome
Mary Lucas
Masataka Kuwana
Nicolette L Verbeet
P356
10.1016/J.AMJMED.2004.04.031
P407
P577
2005-01-01T00:00:00Z